# Intravenous Tranexamic Acid During Rhytidectomy

> **NCT03970213** · PHASE4 · UNKNOWN · sponsor: **Glasgold Group Plastic Surgery** · enrollment: 40 (estimated)

## Conditions studied

- Bleeding
- Bruising Face
- Swelling Lips & Face

## Interventions

- **DRUG:** Tranexamic Acid 100Mg/Ml Inj Vil 10Ml
- **DRUG:** Normal Saline 0.9% Infusion Solution Bag

## Key facts

- **NCT ID:** NCT03970213
- **Lead sponsor:** Glasgold Group Plastic Surgery
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-30
- **Primary completion:** 2019-08-30
- **Final completion:** 2019-08-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03970213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03970213, "Intravenous Tranexamic Acid During Rhytidectomy". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03970213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*